BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32534074)

  • 1. Coenzyme Q 10 supplementation: A potential therapeutic option for the treatment of intrahepatic cholestasis of pregnancy.
    Martinefski MR; Rodriguez MR; Buontempo F; Lucangioli SE; Bianciotti LG; Tripodi VP
    Eur J Pharmacol; 2020 Sep; 882():173270. PubMed ID: 32534074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme Q in pregnant women and rats with intrahepatic cholestasis.
    Martinefski MR; Contin MD; Rodriguez MR; Geréz EM; Galleano ML; Lucangioli SE; Bianciotti LG; Tripodi VP
    Liver Int; 2014 Aug; 34(7):1040-8. PubMed ID: 24118985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D
    Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal coenzyme Q10 deficiency in intrahepatic cholestasis of pregnancy.
    Martinefski MR; Cocucci SE; Di Carlo MB; Vega HR; Lucangioli SE; Perazzi BE; Tripodi VP
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):368-374. PubMed ID: 31477533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X; Kong Y; Zhang F; Wang T; Yan J
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ursodeoxycholic acid on the liver plasma membrane fluidity, hepatic glutathione concentration, hepatic estrogen receptors and progesterone receptors in pregnant rats with ethinylestradiol and progesterone induced intrahepatic cholestasis].
    Shi QY; Kong BH; Ma KD; Zhang XL; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):680-2. PubMed ID: 14728856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
    Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ethanol, lovastatin and coenzyme Q10 treatment on antioxidants and TBA reactive material in liver of rats.
    Loop RA; Anthony M; Willis RA; Folkers K
    Mol Aspects Med; 1994; 15 Suppl():s195-206. PubMed ID: 7752831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Dietary Vitamin E Supplementation on Liver Oxidative Damage in Rats with Water-Immersion Restraint Stress.
    Ohta Y; Yashiro K; Ohashi K; Horikoshi Y; Kusumoto C; Matsura T; Fukuzawa K
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):113-22. PubMed ID: 26052141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
    Rodrigues CM; Marín JJ; Brites D
    Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
    Geenes V; Lövgren-Sandblom A; Benthin L; Lawrance D; Chambers J; Gurung V; Thornton J; Chappell L; Khan E; Dixon P; Marschall HU; Williamson C
    PLoS One; 2014; 9(1):e83828. PubMed ID: 24421907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB; Ovadia C; Lövgren-Sandblom A; Chambers J; Begum S; Seed P; Walker I; Chappell LC; Marschall HU; Williamson C
    BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M; Czajkowski K; Smolarczyk R
    Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
    Bacq Y; Sentilhes L; Reyes HB; Glantz A; Kondrackiene J; Binder T; Nicastri PL; Locatelli A; Floreani A; Hernandez I; Di Martino V
    Gastroenterology; 2012 Dec; 143(6):1492-501. PubMed ID: 22892336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids evoke placental inflammation by activating Gpbar1/NF-κB pathway in intrahepatic cholestasis of pregnancy.
    Zhang Y; Pan Y; Lin C; Zheng Y; Sun H; Zhang H; Wang J; Yuan M; Duan T; Du Q; Chen J
    J Mol Cell Biol; 2016 Dec; 8(6):530-541. PubMed ID: 27402811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.
    Floreani A; Paternoster D; Melis A; Grella PV
    Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):109-13. PubMed ID: 8841797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.
    Glantz A; Reilly SJ; Benthin L; Lammert F; Mattsson LA; Marschall HU
    Hepatology; 2008 Feb; 47(2):544-51. PubMed ID: 17968976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.